The Personal Genetics of Prostate Cancer

Speaker: Dr. Rob Bristow
Original Date: Tuesday, March 11, 2014
 

Join Dr. Bristow as he presents "The Personal Genetics of Prostate Cancer."
 
Overview:
During this webinar, you'll learn about:

  • the genes that are involved in increasing the risk of being diagnosed with prostate cancer
  • the gene abnormalities that lead to aggressive prostate cancer
  • how genetic tests may allow for the individualized treatment of cancer patients

Speaker – Dr. Robert Bristow

Dr. Bristow is currently a Clinician-Scientist at Princess Margaret Cancer Centre where he is treats genitourinary cancers and Professor within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto. His primary research interests are in tumour hypoxia, DNA damage signaling, and prostate cancer genomics in the context of treatment response.
 
Dr. Bristow is the lead PI for the Canadian component of the ICGC whole genome prostate cancer sequencing project (CPC-GENE) and is Head, Campbell Family Research Institute-PMH Prostate Cancer Research Program. He also serves on the Scientific Advisory Board/Committee for Prostate Cancer Canada (co-Chair), the Prostate Cancer Foundation (USA), the Advisory Council for Research (ACOR) of Canadian Cancer Society Research Institute, the Movember Global Strategic Committee and Action Plan (GAP) and the Cancer Research Society. He is past Chair of the Radiation Biology and Cancer Biology Committees of both ASTRO and CARO.
 
Dr Bristow is Editor of the 5th Edition Basic Science of Oncology and has over 200 published papers and book chapters. Dr Bristow has won a number of awards including the Virginia Logan Lectureship (Thomas Jefferson University), the Picchione Scholar Award (Pathology-Dalhousie University), Vivian Sakyly Visiting Professor (Oncology-McGill University) and the John F Ferguson Prostate Cancer Hero Award (Prostate Cancer Canada). He has also won numerous teaching and mentorship awards including the best Postgraduate Teacher at the University of Toronto’s Faculty of Medicine in 2011.  He is twice a Canadian Foundation for Innovation (CFI) awardee. He was made a Canadian Cancer Society Research Scientist in 2004 and an ESTRO Honorary Fellow in 2011.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Donate Now!






Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive